New AI and blockchain-based solutions for clinical trials in healthcare are the new challenges for clinical trial (CT) designers and drug developers. It is necessary to know how these technologies will change CTs and what kind of tools will be implemented in traditional CTs. The high requirement for large numbers of patients to demonstrate sufficient efficacy to regulatory agencies is currently not a good optimisation. The limited number of patients due to advances in precision medicine will lead to the implementation of these technologies.
- Artificial Intelligence applied to CTs
- Blockchain applied to CTs
- NFTs applied to CTs
- Smart Contracts applied to CTs